EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > Sodium 5-((1S,2S)-2-((2R,6S,9S,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)
Sodium 5-((1S,2S)-2-((2R,6S,9S,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl) structure, CAS 1392514-06-5

Sodium 5-((1S,2S)-2-((2R,6S,9S,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)

CAS Number1392514-06-5

Synonyms

Molecular FormulaC35H52O20N8S1

Molecular Weight936.91

Purity98.00%

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1195345 Purity: 98.00%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1392514-06-5 ] Purity: 98.00% SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1392514-06-5
Catalog No.2A-1195345
Molecular FormulaC35H52O20N8S1
Molecular Weight936.91
Purity98.00
PubChem ID384846332
MDL NumberMFCD30478434
InChIInChI=1S/C56H71N9O22S.Na/c1-4-5-6-19-85-33-14-11-29(12-15-33)39-22-35(63-86-39)28-7-9-30(10-8-28)50(75)58-34-16-18-42(71)59-54(79)46-47(72)26(2)24-65(46)56(81)44(38(69)23-41(57)70)61-53(78)45(49(74)48(73)31-13-17-37(68)40(20-31)87-88(82,83)84)62-52(77)36-21-32(67)25-64(36)55(80)43(27(3)66)60-51(34)76;/h7-15,17,20,22,26-27,32,34,36,38,42-49,66-69,71-74H,4-6,16,18-19,21,23-25H2,1-3H3,(H2,57,70)(H,58,75)(H,59,79)(H,60,76)(H,61,78)(H,62,77)(H,82,83,84);/q;+1/p-1/t26-,27+,32+,34-,36-,38+,42+,43-,44-,45-,46-,47-,48-,49-;/m0./s1
InChI KeyUDPAVGDQXRJUNH-GYTNLMEASA-M
MSDSmsds/197039_1_1392514_06_5.pdf
Related Products in Pharmaceutical Intermediates
(S)-3-[4-(2-Methoxyethyl)phenoxy]-1,2-epoxypropane105780-38-92A-2195295
(R)-3-[4-(2-Methoxyethyl)phenoxy]-1,2-epoxypropane133397-54-32A-2195296
(S)-((6-(Propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol2489686-91-92A-1195312
2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4R,6R,9S)-1414933-82-62A-1195331
Sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12S,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopro1392514-05-42A-1195342
(1S,3S)-Solifenacin Hydrochloride180468-38-62A-1195347
4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride1012886-75-72A-2195369
tert-Butyl N-((2S,1S)-2-hydroxycyclohexyl)carbamate145166-06-92A-1195370
(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol1380288-87-82A-2195391
rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate136310-66-22A-1195400
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA